Revolade 25mg Tablet 7's
₹6684.9*
MRP ₹7596.5
12% off
₹6457.5*
MRP ₹7596.5
15% CB
₹1139 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
Revolade 25mg Tablet is used to treat low blood platelet count in patients with idiopathic thrombocytopenic purpura (ITP) and hepatitis C virus (HCV) infections. Revolade 25mg Tablet is also used to treat severe aplastic anaemia (SAA) in adults. Idiopathic thrombocytopenic purpura is an immune condition associated with low levels of platelets. Hepatitis C is an infection and inflammation of the liver caused by the hepatitis C virus. Severe aplastic anaemia is a condition in which the bone marrow doesn't make enough blood cells.
Revolade 25mg Tablet contains 'Eltrombopag', which belongs to the class of 'thrombopoietin receptor agonists'. Thrombopoietin is a glycoprotein hormone that stimulates the formation of megakaryocytes (large bone marrow cells) and further regulates platelet production. Revolade 25mg Tablet works by increasing these large bone marrow cells responsible for the production of platelets. Thus, Revolade 25mg Tablet helps increase these bone marrow cells, thereby stimulating the number of platelets, which further lowers the risk of bleeding.
Take Revolade 25mg Tablet as prescribed by your doctor. In some cases, Revolade 25mg Tablet can cause common side effects like nausea, diarrhoea, headache, muscle pain, tiredness, loss of appetite, fever, anaemia (lack of blood cells), cough and tingling numbness. These side effects are not familiar to everyone who takes Revolade 25mg Tablet and vary individually. If you notice any side effects that are not manageable, please consult your doctor.
Let your doctor know if you have any allergic reactions to Revolade 25mg Tablet or any other medicines before starting Revolade 25mg Tablet. It is essential to inform your doctor if you have any heart, kidney or liver problems, blood disorders, blood clotting problems and cataracts before starting Revolade 25mg Tablet. Consult the doctor if you are pregnant or planning to conceive. Revolade 25mg Tablet is not indicated for use in breastfeeding since it passes into the breast milk. Revolade 25mg Tablet may make you dizzy; hence, drive or operate machinery only when you are mentally alert.
Revolade 25mg Tablet contains 'Eltrombopag,' which belongs to the class of 'thrombopoietin receptor agonists' used to treat low blood platelet count in patients with immune (idiopathic) thrombocytopenic purpura (ITP), hepatitis C virus (HCV) infections and severe aplastic anaemia (SAA) in adults. Revolade 25mg Tablet works by increasing megakaryocytes, the large bone marrow cells responsible for the production of platelets. The increase in these bone marrow cells stimulates the production of platelets. Thus Revolade 25mg Tablet prevents bleeding episodes by increasing the number of platelets in the blood.
If you are known to be allergic to Revolade 25mg Tablet or other medicines, please inform your doctor in advance. Brief your medical history if you have blood clots, clotting disorders (Factor V Leiden), blood disorders like blood cancer, myelodysplastic syndrome, cataracts, liver or kidney diseases before starting Revolade 25mg Tablet. Take Revolade 25mg Tablet at least two hours before or four hours after consuming antacids, mineral and vitamin supplements (iron, calcium, magnesium, aluminium, selenium and zinc), dairy products, calcium-enriched foods and fortified juices since they interfere with the absorption of Revolade 25mg Tablet. Revolade 25mg Tablet is not recommended during pregnancy since it may have harmful effects on the foetus. Consult your doctor before using Revolade 25mg Tablet if you are a breastfeeding mother. Do not drive or operate machinery since Revolade 25mg Tablet may cause side effects like dizziness and tiredness, affecting your ability to concentrate and drive. Avoid or limit alcohol consumption with Revolade 25mg Tablet as it may affect the efficacy of Revolade 25mg Tablet. Revolade 25mg Tablet is not recommended for children less than one year of age in ITP and children less than two years of age in SAA.
Drug-Drug Interactions: Revolade 25mg Tablet may interact with antacids, cholesterol-lowering drugs (statins), vitamin and mineral supplements (iron, calcium, magnesium, aluminium, selenium and zinc), anti-cancer drugs (methotrexate, topotecan), drugs for rheumatoid arthritis (ciclosporin, azathioprine), HIV/AIDS drugs (lopinavir, ritonavir), corticosteroids, and steroid hormones (danazol).
Drug-Food Interactions: Take Revolade 25mg Tablet at least two hours before or four hours after consuming dairy products, calcium-enriched foods, and fortified juices, as these interfere with the absorption of Revolade 25mg Tablet.
Drug-Disease Interactions: People with blood clots, clotting disorders (Factor V Leiden), blood disorders like blood cancer, myelodysplastic syndrome, cataracts, and liver or kidney diseases should consult the doctor before taking Revolade 25mg Tablet.
Immune (idiopathic) thrombocytopenic purpura (ITP): It is an immune condition associated with low levels of platelets, and the blood doesn't clot normally. It occurs when the immune system mistakenly attacks its own platelets. ITP also occurs in children, followed by a viral infection. Symptoms of ITP may include easy bruising, bleeding from gums and nose, blood in urine and stools, heavy menstrual flow and pinpoint-sized reddish-purple spots on the lower legs.
Hepatitis C: It is an infection and inflammation of the liver caused by the hepatitis C virus. This virus can cause both acute and chronic hepatitis. Acute hepatitis C is a short-term illness that may last for six months. Chronic hepatitis C is a long-lasting disease that may lead to other severe liver cancer problems or cirrhosis (inflammation of the liver). Symptoms of hepatitis C include fatigue, nausea, loss of appetite and yellowing of the eyes and skin.
Severe aplastic anaemia (SAA): Aplastic anaemia is also called bone marrow aplasia. It is a condition in which the bone marrow doesn't make enough blood cells. SAA is commonly caused due to the damage of bone marrow. This damage can be a congenital disability or may occur because of radiation, chemotherapy, toxic chemicals, certain drugs and infections. Symptoms of SAA include fatigue, frequent infections, rapid heart rate and bleeding.
Alcohol
Caution
Limit alcohol intake, along with Revolade 25mg Tablet, to attain the maximum efficacy of Revolade 25mg Tablet and rule out any possibility of worsening of side effects.
Pregnancy
Unsafe
Revolade 25mg Tablet is not recommended in pregnancy. It may affect and harm the developing baby. Please consult your doctor if you are pregnant or planning to conceive.
Breast Feeding
Caution
It is not known if Revolade 25mg Tablet is excreted into the breast milk. Please consult your doctor for more information before taking Revolade 25mg Tablet if you are a nursing mother.
Driving
Caution
Revolade 25mg Tablet may cause dizziness and tiredness affecting your ability to concentrate and drive. Hence, it is recommended not to drive or operate machinery until you are mentally alert.
Liver
Caution
Let your doctor know if you have any history of liver diseases before taking Revolade 25mg Tablet. Revolade 25mg Tablet may cause an increase in liver enzymes. Your doctor may start the treatment with a lower dose of Revolade 25mg Tablet.
Kidney
Caution
Revolade 25mg Tablet should be used with caution in cases of renal impairment. It is advised to seek doctor advice before starting Revolade 25mg Tablet if you have any kidney problems.
Children
Caution
Revolade 25mg Tablet is not recommended for children less than one year of age in ITP and children less than two years of age in SAA.
Country of origin
Manufacturer/Marketer address
We provide you with authentic, trustworthy and relevant information
Customers Also Bought
Product Substitutes